On February 22, 2013, the US Food and Drug Administration (FDA)approved KADCYLA with the generic name of ado-trastuzumab emtansine. Unfortunately, some confusion surrounding the drug’s generic name exists. For more information.

The Seventh Annual Meeting of the International Medication Safety Network was held on November 17 & 18, 2012.

The Institute for Safe Medication Practices (ISMP), which operates the National Medication Errors Reporting Program, is warning healthcare providers about repeated incidents of accidental application of “glacial” acetic acid (= 99.5%) to skin or mucous membranes instead of a much more diluted form. Glacial acetic acid is the most concentrated form of acetic acid available. Continue reading →